By Type (Assays, Devices, Consumables), Disease Type (Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes), Deployment (Automated, Manual), End User (Hospitals, Clinics, Diagnostic Laboratories, Academic Institutes, Others), Distribution Channel (Direct, Indirect), Country (Saudi Arabia, South Africa, Egypt, U.A.E., Israel, Rest of Middle East & Africa), Market Trends and Forecast to 2027.
Market Analysis and Insights: Middle East and Africa Diabetic Assays Market
Middle East & Africa diabetic assays market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses that the market is growing with a CAGR of 2.8% in the forecast period of 2020 to 2027and expected to reach USD 73.67 million by 2027 from USD 59.58 million in 2019. Rising government funding for the diagnosis of vascular diseases is accelerating the market growth. For instance, In December 2019, the International Diabetes Federation (IDF) will organize IDF Congress in Korea. IDF Congress is an essential activity of the Federation to provide platform where they will discuss a wide range of diabetes issues. The International Diabetes Federation (IDF) organized IDF Congress in every two years at different location. In 2017 Federation organized IDF Congress in Abu Dhabi where 12,000 delegates from 180 countries participants in it.
Increase in the healthcare expenditure due to growing incidence of disease in the population, innovations in treatment and changing clinical thresholds to diagnose and treat disease. Increase in the healthcare infrastructure is also impacted to increase development activities to implement new advance technology in the product of diabetic assays and more healthcare expenditure changing R&D models in research-based. In these conditions, the use of developed of diabetes diagnostics glucose assay and diabetes diagnostics HBA1c assay.
The government plays major role while taking initiative for the diabetes diseases because diabetes is a leading chronic disease. Growing diabetes expenditure to support and fund to diagnosis and monitoring of diabetes, for instance, according to International Diabetes Federation (IDF), in 2017, In Saudi Arabia the total healthcare expenditure on diabetes was USD 3,276,000.0 million.
This diabetic assays market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.
Middle East & Africa Diabetic Assays Market Scope and Market Size
Middle East & Africa diabetic assays market is segmented on the basis of type, disease type, deployment, end user and distribution channel. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
On the basis of type, the market is segmented into device, assays and consumables. In 2020, the assays segment is dominating the assays provide the accurate measurement of diabetes diagnosed using glucose tests.
The advancement in assays such as quick identification of diabetes through blood samples major vendors augmented to the market growth of diabetes assays market. For instance, In July 2017, Bio-Rad Laboratories Inc received approval from the FDA for D-10 Hemoglobin A1c Program, a diagnostic product which will provide accurate test results and early diagnosis for patient health improvement. Through this, the company has expanded its product offering and will also provide diagnosis and identification for the patients at risk of developing the diabetes at an earlier stage.
On the basis of disease, the diabetic assays market is segmented into type 1 diabetes, type 2 diabetes and gestational diabetes. For instance, in 2019, International Diabetes Federation (IDF) projected there was an estimated 463 million people which were affected from diabetes. In which Middle East & Africa comprises the total cases of diabetes around 58 million which was project number of cases was estimated as 108 million respectively in 2045. This growing number of diseases and majority around 90% of diseases is type 2 diabetes accelerating the diagnosis of cases and leading to market growth.
On the basis of deployment, the diabetic assays market is segmented into automated and manual. In 2020, automated segment is dominating and growing with the highest CAGR because of the new development of analyzers and associated software which provides automated operational workflow while diagnosis procedure.
On the basis of end-user, the diabetic assays market is segmented into hospitals, clinics, diagnostic laboratories, academic institutes and others. In 2020, hospitals segment is dominating as well as growing in the market as the diabetes assays due to the wide availability of diagnostic procedures of diabetes in hospitals laboratories which is performed under trained professionals for analysis of blood glucose level of diabetic patient.
On the basis of distribution channel, the diabetic assays market is segmented into direct and indirect. In 2020, the direct segment is dominating the Middle East & Africa diabetic assays market and is growing with the highest CAGR as the hospitals, established diagnostic laboratories and among others prefer the product supply directly from the manufacturers as the offering through this mode are lower in cost and are at discounted prices. Further, massive supply of such product is directly maintained by the manufacturer itself and due to these reasons this segment is leading in the forecasted period.
Diabetic Assays Market Country Level Analysis
Middle East & Africa diabetic assays market is analysed and market size information is provided by country, by type, disease type, deployment, end user and distribution channel as referenced above.
The countries covered in the diabetic assays market report are Saudi Arabia, South Africa, Egypt, U.A.E., Israel, and rest of Middle East & Africa in Middle East & Africa.
Country Level Analysis, By Type
Middle East & Africa dominates the diabetic assays market as the Saudi Arabia is leader in diabetic assays manufacturing and major leaders are generating revenue from Saudi Arabia due to growing awareness and high healthcare expenditure due to diabetes is USD 3,276,000.00 million in Middle East & Africa region population requires high detection of diabetes assays for the identification and detection of diabetes diseases.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of regional brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Growing Awareness towards the Detection of Diabetes and New Technology Penetration
Middle East & Africa diabetic assays market also provides you with detailed market analysis for every country growth in healthcare industry with diabetic assays sales, assays and devices sales, impact of technological development in assays and changes in regulatory scenarios with their support for the diabetic assays market. The data is available for historic period 2010 to 2018.
Competitive Landscape and Diabetic assays Market Share Analysis
Middle East & Africa diabetic assays market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, Middle East & Africa presence, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to Middle East & Africa diabetic assays market.
The major players covered in the report are Abbott, Danaher, Merck KGaA, SIEMENS HEALTHINEERS AG, Bio-Rad Laboratories, Inc., DiaSorin S.p.A., EKF Diagnostics, DRG INSTRUMENTS GMBH, PTS Diagnostics, Ortho Clinical Diagnostics, Medipan GmbH, Diagnostic Automation/Cortez Diagnostics Inc., Diazyme Laboratories, Inc., Ethos Biosciences, Inc., BioAssay Systems, Tosoh Corporation, Abnova Corporation, Monobind Inc, ORGENTEC Diagnostika GmbH, ALPCO., among other domestic and regional players. Diabetic assays market share data is available for Middle East & Africa separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
Many product developments are also initiated by the companies worldwide which are also accelerating the Middle East & Africa diabetic assays market.
- In February 2018, Abnova Corporation (China) declared that it has advances AC TN4 IN Vitro Diagnostic (IVD) Biomarker for lung adenocarcinoma clinical trial in Japan gaining PMDA permission. This development will enhance the product portfolio of the company in the market.
- In January 2019, Siemens Healthineers AG introduced its wide range of products and services at MedLab Middle East 2019 in its main areas of laboratory diagnostics and molecular medicine. MedLab is the only medical laboratory operation that offers vendors a chance to meet a diverse audience of customers. More than 19,610 health labs and practitioners from manufacturers to senior end-users accepted the 2019 version in the search for the latest innovative products. With this exhibition the company have showed there products to extend its market global presence in field of in-vitro diagnostics.
Partnership, joint ventures and other strategies enhances the company market share with increased coverage and presence. It also provides the benefit for organisation to improve their offering for diabetic assays through expanded model range.
Customization Available : Middle East and Africa Diabetic Assays Market
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customised to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analysed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.